Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity

New, tricyclic compounds containing a sulfonyl moiety in their structure, as potential safer COX inhibitors, were designed and synthesized. New derivatives have three conjugated rings and a sulfonyl group. A third ring, i.e., an oxazine, oxazepine or oxazocin, has been added to the 1,2-benzothiazine...

Full description

Bibliographic Details
Main Authors: Jadwiga Maniewska, Benita Wiatrak, Żaneta Czyżnikowska, Berenika M. Szczęśniak-Sięga
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/15/7818
_version_ 1797525576026685440
author Jadwiga Maniewska
Benita Wiatrak
Żaneta Czyżnikowska
Berenika M. Szczęśniak-Sięga
author_facet Jadwiga Maniewska
Benita Wiatrak
Żaneta Czyżnikowska
Berenika M. Szczęśniak-Sięga
author_sort Jadwiga Maniewska
collection DOAJ
description New, tricyclic compounds containing a sulfonyl moiety in their structure, as potential safer COX inhibitors, were designed and synthesized. New derivatives have three conjugated rings and a sulfonyl group. A third ring, i.e., an oxazine, oxazepine or oxazocin, has been added to the 1,2-benzothiazine skeleton. Their anti-COX-1/COX-2 and cytotoxic effects in vitro on NHDF cells, together with the ability to interact with model membranes and the influence on reactive oxygen species and nitric oxide, were studied. Additionally, a molecular docking study was performed to understand the binding interaction of the compounds with the active site of cyclooxygenases. For the abovementioned biological evaluation of new tricyclic 1,2-benzothiazine derivatives, the following techniques and procedures were employed: the differential scanning calorimetry, the COX colorimetric inhibitor screening assay, the MTT, DCF-DA and Griess assays. All of the compounds studied demonstrated preferential inhibition of COX-2 compared to COX-1. Moreover, all the examined tricyclic 1,2-thiazine derivatives interacted with the phospholipid model membranes. Finally, they neither have cytotoxic potency, nor demonstrate significant influence on the level of reactive oxygen species or nitric oxide. Overall, the tricyclic 1,2-thiazine derivatives are good starting points for future pharmacological tests as a group of new anti-inflammatory agents.
first_indexed 2024-03-10T09:15:48Z
format Article
id doaj.art-533533fe86cd4a8296eabbe8191f847f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T09:15:48Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-533533fe86cd4a8296eabbe8191f847f2023-11-22T05:38:52ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-012215781810.3390/ijms22157818Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory ActivityJadwiga Maniewska0Benita Wiatrak1Żaneta Czyżnikowska2Berenika M. Szczęśniak-Sięga3Department of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, PolandDepartment of Pharmacology, Faculty of Medicine, Wroclaw Medical University, J. Mikulicza-Radeckiego 2, 50-345 Wrocław, PolandDepartment of Inorganic Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211a, 50-556 Wrocław, PolandDepartment of Medicinal Chemistry, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wrocław, PolandNew, tricyclic compounds containing a sulfonyl moiety in their structure, as potential safer COX inhibitors, were designed and synthesized. New derivatives have three conjugated rings and a sulfonyl group. A third ring, i.e., an oxazine, oxazepine or oxazocin, has been added to the 1,2-benzothiazine skeleton. Their anti-COX-1/COX-2 and cytotoxic effects in vitro on NHDF cells, together with the ability to interact with model membranes and the influence on reactive oxygen species and nitric oxide, were studied. Additionally, a molecular docking study was performed to understand the binding interaction of the compounds with the active site of cyclooxygenases. For the abovementioned biological evaluation of new tricyclic 1,2-benzothiazine derivatives, the following techniques and procedures were employed: the differential scanning calorimetry, the COX colorimetric inhibitor screening assay, the MTT, DCF-DA and Griess assays. All of the compounds studied demonstrated preferential inhibition of COX-2 compared to COX-1. Moreover, all the examined tricyclic 1,2-thiazine derivatives interacted with the phospholipid model membranes. Finally, they neither have cytotoxic potency, nor demonstrate significant influence on the level of reactive oxygen species or nitric oxide. Overall, the tricyclic 1,2-thiazine derivatives are good starting points for future pharmacological tests as a group of new anti-inflammatory agents.https://www.mdpi.com/1422-0067/22/15/7818synthesistricyclic compounds1,2-thiazinecyclooxygenase inhibitionmodel membraneDSC
spellingShingle Jadwiga Maniewska
Benita Wiatrak
Żaneta Czyżnikowska
Berenika M. Szczęśniak-Sięga
Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
International Journal of Molecular Sciences
synthesis
tricyclic compounds
1,2-thiazine
cyclooxygenase inhibition
model membrane
DSC
title Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
title_full Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
title_fullStr Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
title_full_unstemmed Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
title_short Synthesis of New Tricyclic 1,2-Thiazine Derivatives with Anti-Inflammatory Activity
title_sort synthesis of new tricyclic 1 2 thiazine derivatives with anti inflammatory activity
topic synthesis
tricyclic compounds
1,2-thiazine
cyclooxygenase inhibition
model membrane
DSC
url https://www.mdpi.com/1422-0067/22/15/7818
work_keys_str_mv AT jadwigamaniewska synthesisofnewtricyclic12thiazinederivativeswithantiinflammatoryactivity
AT benitawiatrak synthesisofnewtricyclic12thiazinederivativeswithantiinflammatoryactivity
AT zanetaczyznikowska synthesisofnewtricyclic12thiazinederivativeswithantiinflammatoryactivity
AT berenikamszczesniaksiega synthesisofnewtricyclic12thiazinederivativeswithantiinflammatoryactivity